PuSH - Publikationsserver des Helmholtz Zentrums München

Lian, F.* ; Xing, X.* ; Yuan, G.* ; Schäfer, C.* ; Rauser, S. ; Walch, A.K. ; Röcken, C.* ; Ebeling, M.* ; Wright, M.B.* ; Schmid, R.M.* ; Ebert, M.P.* ; Burgermeister, E.*

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.

Biochem. J. 438, 315-323 (2011)
Verlagsversion Forschungsdaten DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Bile acids from duodenogastric reflux promote inflammation and increase the risk for gastro-oesophageal cancers. FXR (farnesoid X receptor/NR1H4) is a transcription factor regulated by bile acids such as CDCA (chenodeoxycholic acid). FXR protects the liver and the intestinal tract against bile acid overload; however, a functional role for FXR in the stomach has not been described. We detected FXR expression in the normal human stomach and in GC (gastric cancer). FXR mRNA and protein were also present in the human GC cell lines MKN45 and SNU5, but not in the AGS cell line. Transfection of FXR into AGS cells protected against TNFα (tumour necrosis factor α)-induced cell damage. We identified K13 (keratin 13), an anti-apoptotic protein of desmosomes, as a novel CDCA-regulated FXR-target gene. FXR bound to a conserved regulatory element in the proximal human K13 promoter. Gastric expression of K13 mRNA was increased in an FXR-dependent manner by a chow diet enriched with 1% (w/w) CDCA and by indomethacin (35 mg/kg of body weight intraperitoneal) in C57BL/6 mice. FXR-deficient mice were more susceptible to indomethacin-induced gastric ulceration than their WT (wild-type) littermates. These results suggest that FXR increases the resistance of human and murine gastric epithelial cells to inflammation-mediated damage and may thus participate in the development of GC.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter bile acid; chenodeoxycholic acid (CDCA); farnesoid X receptor (FXR); keratin; gastric cancer; stomach
ISSN (print) / ISBN 0264-6021
e-ISSN 1470-8728
Zeitschrift Biochemical Journal / Reviews
Quellenangaben Band: 438, Heft: 2, Seiten: 315-323 Artikelnummer: , Supplement: ,
Verlag Portland Press
Begutachtungsstatus